These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20926473)

  • 21. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silent non-alcoholic fatty liver disease-a clinical-histological study.
    Sorrentino P; Tarantino G; Conca P; Perrella A; Terracciano ML; Vecchione R; Gargiulo G; Gennarelli N; Lobello R
    J Hepatol; 2004 Nov; 41(5):751-7. PubMed ID: 15519647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship of serum iron and ferritin with the indicators for hepatic fibrosis].
    Huang CW; Bai L; Cai JJ; Guo W; Lan L
    Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):466-8. PubMed ID: 12754132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver.
    Hirsch S; Poniachick J; Avendaño M; Csendes A; Burdiles P; Smok G; Diaz JC; de la Maza MP
    Nutrition; 2005 Feb; 21(2):137-41. PubMed ID: 15723740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.
    Tahan V; Canbakan B; Balci H; Dane F; Akin H; Can G; Hatemi I; Olgac V; Sonsuz A; Ozbay G; Yurdakul I; Senturk H
    Hepatogastroenterology; 2008; 55(85):1433-8. PubMed ID: 18795706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects.
    Sato M; Kamada Y; Takeda Y; Kida S; Ohara Y; Fujii H; Akita M; Mizutani K; Yoshida Y; Yamada M; Hougaku H; Takehara T; Miyoshi E
    Liver Int; 2015 Mar; 35(3):925-35. PubMed ID: 25627311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
    Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
    Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological correlations in a series of adult patients with non-alcoholic fatty liver disease.
    Fotiadu A; Gagalis A; Akriviadis E; Kotoula V; Sinakos E; Karkavelas G; Hytiroglou P
    Pathol Int; 2010 Feb; 60(2):87-92. PubMed ID: 20398192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease.
    Yilmaz Y; Yonal O; Eren F; Kurt R; Celikel CA; Ozdogan O; Imeryuz N; Kalayci C; Avsar E
    Clin Chem Lab Med; 2011 Jan; 49(1):93-7. PubMed ID: 21077793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease.
    Aigner E; Strasser M; Haufe H; Sonnweber T; Hohla F; Stadlmayr A; Solioz M; Tilg H; Patsch W; Weiss G; Stickel F; Datz C
    Am J Gastroenterol; 2010 Sep; 105(9):1978-85. PubMed ID: 20407430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
    Angulo P; Alba LM; Petrovic LM; Adams LA; Lindor KD; Jensen MD
    J Hepatol; 2004 Dec; 41(6):943-9. PubMed ID: 15582127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.
    Tiftikci A; Atug O; Yilmaz Y; Eren F; Ozdemir FT; Yapali S; Ozdogan O; Celikel CA; Imeryuz N; Tozun N
    Arch Med Res; 2009 May; 40(4):294-8. PubMed ID: 19608019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.
    Wong VW; Chan HL; Hui AY; Chan KF; Liew CT; Chan FK; Sung JJ
    Aliment Pharmacol Ther; 2004 Jul; 20(1):45-9. PubMed ID: 15225170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease.
    Komatsu M; Yazaki M; Tanaka N; Sano K; Hashimoto E; Takei Y; Song YZ; Tanaka E; Kiyosawa K; Saheki T; Aoyama T; Kobayashi K
    J Hepatol; 2008 Nov; 49(5):810-20. PubMed ID: 18620775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.
    Lydatakis H; Hager IP; Kostadelou E; Mpousmpoulas S; Pappas S; Diamantis I
    Liver Int; 2006 Sep; 26(7):864-71. PubMed ID: 16911470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver.
    Loguercio C; De Simone T; D'Auria MV; de Sio I; Federico A; Tuccillo C; Abbatecola AM; Del Vecchio Blanco C;
    Dig Liver Dis; 2004 Jun; 36(6):398-405. PubMed ID: 15248380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.